SG170051A1 - T cell assays - Google Patents

T cell assays

Info

Publication number
SG170051A1
SG170051A1 SG201101440-4A SG2011014404A SG170051A1 SG 170051 A1 SG170051 A1 SG 170051A1 SG 2011014404 A SG2011014404 A SG 2011014404A SG 170051 A1 SG170051 A1 SG 170051A1
Authority
SG
Singapore
Prior art keywords
cell responses
cell assays
cell
novel
antigens
Prior art date
Application number
SG201101440-4A
Other languages
English (en)
Inventor
Mathew Baker
Francis J Carr
Alyson Rust
Laura Davies
Original Assignee
Antitope Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0604170A external-priority patent/GB0604170D0/en
Priority claimed from GB0619374A external-priority patent/GB0619374D0/en
Priority claimed from GB0620123A external-priority patent/GB0620123D0/en
Application filed by Antitope Ltd filed Critical Antitope Ltd
Publication of SG170051A1 publication Critical patent/SG170051A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
SG201101440-4A 2006-03-02 2007-03-02 T cell assays SG170051A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0604170A GB0604170D0 (en) 2006-03-02 2006-03-02 T cell assays
GB0619374A GB0619374D0 (en) 2006-09-29 2006-09-29 T cell asays
GB0620123A GB0620123D0 (en) 2006-10-11 2006-10-11 T cell assays

Publications (1)

Publication Number Publication Date
SG170051A1 true SG170051A1 (en) 2011-04-29

Family

ID=38191208

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101440-4A SG170051A1 (en) 2006-03-02 2007-03-02 T cell assays

Country Status (14)

Country Link
US (1) US20090221024A1 (fr)
EP (1) EP1989544B1 (fr)
JP (1) JP5161798B2 (fr)
KR (1) KR101361887B1 (fr)
AT (1) ATE514081T1 (fr)
AU (1) AU2007220300A1 (fr)
CA (1) CA2644540C (fr)
DK (1) DK1989544T3 (fr)
HK (1) HK1126274A1 (fr)
PL (1) PL1989544T3 (fr)
PT (1) PT1989544E (fr)
RU (1) RU2476884C2 (fr)
SG (1) SG170051A1 (fr)
WO (1) WO2007099341A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE20090514A1 (en) 2009-07-06 2011-02-16 Opsona Therapeutics Ltd Humanised antibodies and uses therof
JPWO2011027810A1 (ja) * 2009-09-03 2013-02-04 独立行政法人理化学研究所 アレルゲン特異的リンパ球の検出方法
BR112012004983A2 (pt) 2009-09-06 2021-02-23 Protab Ltd. anticorpos humanizados específicos para métodos de pepetídeo-6 derivado de hsp65
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
WO2013119947A1 (fr) 2012-02-09 2013-08-15 Baylor College Of Medicine Mélange de peptides pour produire des ctlmultiviraux avec une large spécificité
KR102390445B1 (ko) 2012-12-26 2022-04-25 온코시너지, 인코포레이티드 항-인테그린 β1 항체 조성물 및 이의 이용 방법
WO2014180490A1 (fr) * 2013-05-10 2014-11-13 Biontech Ag Prédiction de l'immunogénicité d'épitopes de lymphocytes t
CA2998649A1 (fr) 2015-09-18 2017-03-23 Baylor College Of Medicine Identification d'antigene immunogene a partir d'un pathogene et correlation avec l'efficacite clinique
US11733235B2 (en) 2016-12-27 2023-08-22 Chugai Seiyaku Kabushiki Kaisha Method for evaluating immunogenicity of test substance
RU2722648C2 (ru) * 2018-11-16 2020-06-02 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Способ проверки иммуногенности вакцинных антигенов для получения высокоэффективных вакцин против опасных инфекций

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ332897A (en) * 1996-04-23 2000-04-28 Harvard College Methods and compositions for modulating production of a T helper type 2 (Th2)-associated cytokine by regulating transcription factor activity in association with a Nuclear Factor of Activated T cells (NF-AT) protein
JP2001520013A (ja) * 1997-10-10 2001-10-30 ビーエーエスエフ アクチェンゲゼルシャフト Ｔ細胞受容体−会合分子（ｔａｒｍｓ）及びその使用方法
SI1071752T1 (en) * 1998-04-21 2003-12-31 Micromet Ag CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
EP1241249A1 (fr) * 2001-03-12 2002-09-18 Gerold Schuler Lymphocytes T CD4+CD25+ régulateurs provenant du sang humain
US20050220800A1 (en) * 2002-05-01 2005-10-06 Scott Power D Cytokines and cytokine receptors with reduced immunogenicity
CA2759572A1 (fr) * 2002-08-08 2004-02-19 Baylor College Of Medicine Isolation et identification de cellules t
AU2003285586A1 (en) * 2002-12-03 2004-06-23 Medical Research Council Regulatory t-cells

Also Published As

Publication number Publication date
PL1989544T3 (pl) 2012-01-31
RU2476884C2 (ru) 2013-02-27
RU2008136561A (ru) 2010-04-10
CA2644540A1 (fr) 2007-09-07
KR101361887B1 (ko) 2014-02-21
US20090221024A1 (en) 2009-09-03
JP2009528044A (ja) 2009-08-06
EP1989544B1 (fr) 2011-06-22
CA2644540C (fr) 2014-09-30
AU2007220300A1 (en) 2007-09-07
HK1126274A1 (en) 2009-08-28
KR20080109008A (ko) 2008-12-16
DK1989544T3 (da) 2011-09-26
ATE514081T1 (de) 2011-07-15
WO2007099341A1 (fr) 2007-09-07
PT1989544E (pt) 2011-09-26
JP5161798B2 (ja) 2013-03-13
EP1989544A1 (fr) 2008-11-12

Similar Documents

Publication Publication Date Title
HK1126274A1 (en) T cell assays t
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
WO2015070037A3 (fr) Conjugués de polynucléotides et procédés de détection d'analytes
WO2013074520A3 (fr) Détection, isolement et analyse de cellules rares dans des liquides biologiques
DK1766400T3 (da) Fremgangsmåde til at udföre fuldblodsanalyser
WO2007062090A3 (fr) Procedes et compositions lies a des analyses de lymphocytes b
NZ609824A (en) Immunochromatography devices, methods and kits
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
WO2005075986A3 (fr) Procede et kit de mesure de l'activation des neutrophiles
AR053948A1 (es) Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente
EP3851856A3 (fr) Procédé, réseau et son utilisation
WO2007001737A3 (fr) Procedes et compositions de detection du virus de l'herpes simplex de type 2
MX2009006205A (es) Inmunoensayo de multiples analitos.
ATE489632T1 (de) Antigennachweis
MX2009010751A (es) Composiciones y metodos de deteccion.
BRPI0513596A (pt) anticorpo enriquecido para detecção de infecção micobacteriana, métodos de uso e teste diagnóstico empregando o mesmo
NZ590219A (en) Sample carrier for effecting chemical assays with mixing and detecting zone separated by a pathway with inlet.
WO2009023331A3 (fr) Anticorps et procédés améliorés de manipulation d'un échantillon test destinés à être utilisés dans des dosages pour myélopéroxidase
RU2009128762A (ru) Способ и набор для иммуноферментного определения функциональной активности компонента с3 комплемента человека
WO2007120166A3 (fr) Réseau miniaturisé d'expression de protéines in vitro
WO2011113813A3 (fr) Dosage
ATE533053T1 (de) Nicht-elispot-test
CA2467904A1 (fr) Compositions et methodes pour le diagnostic precoce precis de la grossesse
WO2007001991A3 (fr) Detection d'echantillons adulteres
WO2008005940A3 (fr) Isolement d'analytes